Patents by Inventor Anette Brunner-Schwarz

Anette Brunner-Schwarz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE
    Publication number: 20230028647
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: May 18, 2022
    Publication date: January 26, 2023
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE
    Publication number: 20210038514
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: July 6, 2020
    Publication date: February 11, 2021
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Pharmaceutical Composition Comprising a GLP-1-Agonist and Methionine
    Publication number: 20190142747
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: February 1, 2019
    Publication date: May 16, 2019
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Pharmaceutical composition comprising a GLP-1-agonist and methionine
    Patent number: 10028910
    Abstract: A liquid composition comprising a GLP-1 agonist and/or a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivatives where appropriate.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: July 24, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Pharmaceutical Composition Comprising a GLP-1-Agonist and Methionine
    Publication number: 20170326069
    Abstract: A liquid composition comprising a GLP-1 agonist and/or a pharocoligically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivatives where appropriate.
    Type: Application
    Filed: May 15, 2017
    Publication date: November 16, 2017
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Pharmaceutical composition comprising a GLP-1 agonist and methionine
    Patent number: 9707176
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 18, 2017
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST AND METHIONINE
    Publication number: 20120283179
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 8, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Acidic Insulin Preparations Having Improved Stability
    Publication number: 20100216692
    Abstract: The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
    Type: Application
    Filed: May 4, 2010
    Publication date: August 26, 2010
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette BRUNNER-SCHWARZ, Norbert LILL
  • Acidic insulin preparations having improved stability
    Patent number: 7713930
    Abstract: The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: May 11, 2010
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Anette Brunner-Schwarz, Norbert Lill
  • Acidic Insulin Preparations Having Improved Stability
    Publication number: 20090082255
    Abstract: The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
    Type: Application
    Filed: December 4, 2008
    Publication date: March 26, 2009
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Norbert Lill
  • Acidic insulin preparations having improved stability
    Patent number: 7476652
    Abstract: The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: January 13, 2009
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Anette Brunner-Schwarz, Norbert Lill
  • Acidic insulin preparations with improved stability
    Publication number: 20050171009
    Abstract: The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
    Type: Application
    Filed: March 25, 2005
    Publication date: August 4, 2005
    Applicant: AVENTIS PHARMA DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Norbert Lill
  • Acidic insulin preparations having improved stability
    Publication number: 20040048783
    Abstract: The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 11, 2004
    Applicant: AVENTIS PHARMA DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Norbert Lill